Fiorella Di Pastena

Hamilton, ON L8N3Z5, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

GDF15 suppresses liver inflammation independently of weight loss through neuroendocrine glucocorticoid signaling.

GDF15 suppresses liver inflammation independently of weight loss through neuroendocrine glucocorticoid signaling.

Journal: Cell metabolism

Published: December 11, 2025

Canagliflozin is a novel androgen receptor pathway inhibitor for castrate-sensitive and castrate-resistant prostate cancer.

Canagliflozin is a novel androgen receptor pathway inhibitor for castrate-sensitive and castrate-resistant prostate cancer.

Journal: Cancer letters

Published: October 06, 2025

ASCC3 promotes chemosensitivity in colorectal cancer cells.

ASCC3 promotes chemosensitivity in colorectal cancer cells.

Journal: Scientific reports

Published: September 25, 2025

Dual inhibition of ACLY and ACSS2 by EVT0185 reduces steatosis, hepatic stellate cell activation, and fibrosis in mouse models of MASH.

Dual inhibition of ACLY and ACSS2 by EVT0185 reduces steatosis, hepatic stellate cell activation, and fibrosis in mouse models of MASH.

Journal: Cell metabolism

Published: March 26, 2025

Correction to "Novel N-(Heterocyclylphenyl)benzensulfonamide Sharing an Unreported Binding Site with T-Cell Factor 4 at the β-Catenin Armadillo Repeats Domain as Anticancer Agent".

Correction to "Novel N-(Heterocyclylphenyl)benzensulfonamide Sharing an Unreported Binding Site with T-Cell Factor 4 at the β-Catenin Armadillo Repeats Domain as Anticancer Agent".

Journal: ACS pharmacology & translational science

Published: March 08, 2025

Salsalate improves the anti-tumor efficacy of lenvatinib in MASH-driven hepatocellular carcinoma.

Salsalate improves the anti-tumor efficacy of lenvatinib in MASH-driven hepatocellular carcinoma.

Journal: JHEP reports : innovation in hepatology

Published: August 09, 2024

Growth differentiation factor 15 (GDF15) predicts relapse free and overall survival in unresected locally advanced non-small cell lung cancer treated with chemoradiotherapy.

Growth differentiation factor 15 (GDF15) predicts relapse free and overall survival in unresected locally advanced non-small cell lung cancer treated with chemoradiotherapy.

Journal: Radiation oncology (London, England)

Published: April 14, 2024

MYC upstream region orchestrates resistance to PI3K inhibitors in cancer cells through FOXO3a-mediated autophagic adaptation.

MYC upstream region orchestrates resistance to PI3K inhibitors in cancer cells through FOXO3a-mediated autophagic adaptation.

Journal: Oncogene

Published: March 12, 2024

Novel N-(Heterocyclylphenyl)benzensulfonamide Sharing an Unreported Binding Site with T-Cell Factor 4 at the β-Catenin Armadillo Repeats Domain as an Anticancer Agent.

Novel N-(Heterocyclylphenyl)benzensulfonamide Sharing an Unreported Binding Site with T-Cell Factor 4 at the β-Catenin Armadillo Repeats Domain as an Anticancer Agent.

Journal: ACS pharmacology & translational science

Published: May 17, 2023

ACLY inhibition promotes tumour immunity and suppresses liver cancer.

ACLY inhibition promotes tumour immunity and suppresses liver cancer.

Journal: Nature

Published: May 10, 2023

The Mechanism of Action of Biguanides: New Answers to a Complex Question.

The Mechanism of Action of Biguanides: New Answers to a Complex Question.

Journal: Cancers

Published: May 25, 2022

Discovery of novel human lactate dehydrogenase inhibitors: Structure-based virtual screening studies and biological assessment.

Discovery of novel human lactate dehydrogenase inhibitors: Structure-based virtual screening studies and biological assessment.

Journal: European journal of medicinal chemistry

Published: April 15, 2022

Showing 1-12 of 20

Last Updated: 09/26/2026